Original NAD+: Discovery & Research History
NAD+ (Nicotinamide Adenine Dinucleotide) — how it was originally identified, and what it has been studied for since.
How NAD+ Was Discovered
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, identified long before it became a longevity-research target for its central role in the electron transport chain that produces cellular energy and its activation of the sirtuin family of proteins linked to cellular stress resistance.
What turned NAD+ into a major longevity-research focus was the well-documented finding that its levels decline with age. That observation reframed a basic metabolic coenzyme as a potential intervention target, driving research into both direct NAD+ administration and precursor molecules the body converts into NAD+.
What NAD+ Has Been Studied For
Human trial data comes largely from NAD+ precursor molecules rather than NAD+ administered directly by injection. The first human trial of a NAD+ precursor found that single oral doses of nicotinamide riboside raised blood NAD+ levels in a dose-dependent manner, establishing the basic pharmacokinetics that later precursor and direct-administration research has built on.
- Cellular energy metabolism research
- Sirtuin activation studies
- Precursor and direct-administration pharmacokinetics
NAD+ discovery & history questions
Does NAD+'s research history mean it's approved for a particular use?
No. This page describes how NAD+ was originally identified and what it has been studied for since — it is historical and educational context, not a claim about current regulatory approval, safety, or legal status anywhere. KYIN Peptides sells NAD+ strictly for laboratory research use.
What has NAD+ been studied for in research?
NAD+ is studied for cellular energy metabolism and sirtuin activation in longevity research, with human trial data primarily coming from precursor-molecule studies.
Looking for NAD+ specs and pricing?
View purity, available sizes, and pricing on the product page.